PYC Therapeutics Ltd
OTC:PYCXF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
PYC Therapeutics Ltd
OTC:PYCXF
|
AU |
|
Northern Minerals Ltd
ASX:NTU
|
AU |
|
F
|
Fair Value REIT-AG
F:FVI
|
DE |
|
H
|
Hankuk Steel Wire Co Ltd
KOSDAQ:025550
|
KR |
|
Symrise AG
F:SY1U
|
DE |
|
A
|
Adventa Bhd
KLSE:ADVENTA
|
MY |
|
E
|
El Capitan Precious Metals Inc
OTC:ECPN
|
US |
|
K
|
Keyang Electric Machinery Co Ltd
KRX:012200
|
KR |
|
Astrotech Corp
NASDAQ:ASTC
|
US |
|
Family Office of America Inc
OTC:FOFA
|
US |
|
Bioretec Oy
F:0TN
|
FI |
|
Cybertrust Japan Co Ltd
F:5U2
|
JP |
|
Guoco Group Ltd
HKEX:53
|
HK |
|
C
|
CD Projekt SA
WSE:CDR
|
PL |
Bankruptcy Probability
PYC Therapeutics Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
PYC Therapeutics Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AU |
|
PYC Therapeutics Ltd
ASX:PYC
|
1.9B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
504.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
237.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
193.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
132.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
79.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
58B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
48.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
40.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
PYC Therapeutics Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, PYC Therapeutics Ltd has total debt of 268.5k AUD. This includes both short-term (0 AUD) and long-term (268.5k AUD) debt.
You can find a full breakdown on its Balance Sheet.